1. Home
  2. WNC vs ENTA Comparison

WNC vs ENTA Comparison

Compare WNC & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WNC

Wabash National Corporation

HOLD

Current Price

$9.73

Market Cap

325.8M

Sector

Industrials

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$11.90

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNC
ENTA
Founded
1985
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
325.8M
382.7M
IPO Year
2009
2012

Fundamental Metrics

Financial Performance
Metric
WNC
ENTA
Price
$9.73
$11.90
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$11.00
$20.40
AVG Volume (30 Days)
641.9K
187.1K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
3.84%
N/A
EPS Growth
179.22
29.93
EPS
N/A
N/A
Revenue
$2,027,489,000.00
$102,814,000.00
Revenue This Year
$10.65
$7.76
Revenue Next Year
$14.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.81
16.48
52 Week Low
$6.63
$6.44
52 Week High
$12.94
$17.15

Technical Indicators

Market Signals
Indicator
WNC
ENTA
Relative Strength Index (RSI) 67.24 41.97
Support Level $8.58 $11.92
Resistance Level $9.48 $13.97
Average True Range (ATR) 0.44 0.75
MACD 0.19 -0.08
Stochastic Oscillator 81.67 33.69

Price Performance

Historical Comparison
WNC
ENTA

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: